Abstract: Transcriptional regulators, including the cohesin complex member STAG2, are recurrently mutated in cancer. The role of STAG2 in gene regulation, hematopoiesis, and tumor suppression remains unresolved. We show Stag2 deletion in hematopoietic stem/progenitor cells (HSPC) results in altered hematopoietic function, increased selfrenewal, and impaired differentiation. ChIP-sequencing revealed that while Stag2 and Stag1 can bind the same loci, a component of Stag2 binding sites are unoccupied by Stag1 even in Stag2-deficient HSPCs. While concurrent loss of Stag2 and Stag1 abrogated hematopoiesis, Stag2 loss alone decreased chromatin accessibility and transcription of lineage-specification genes, including Ebf1 and Pax5, leading to blunted HSPC commitment to the B-cell lineage. Our data illustrate a role for Stag2 in transformation and transcriptional dysregulation distinct from its shared role with Stag1 in chromosomal segregation.
proportion of LSK (Lineage -Sca1 + cKit + ) cells ( Figure 1A ). Figure S2A ). We also observed a significant increase in granulocyte macrophage progenitors (GMP: Lineage -cKit + Sca1 -Cd34 + Fcg + ; p<0.001; Figure S2B -C) in the Stag2-deficient 5 hematopoietic compartment.
We next investigated the role of Stag2 and Stag1 in hematopoietic self-renewal. Stag2-deficient hematopoietic cells displayed increased serial replating capacity in methylcellulose culture assays (≥7 platings), whereas WT and Stag1 KO cells were not able to form colonies beyond 3 platings
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( Figure 1B ). We next performed competitive transplantation assays to assess the impact of Stag2/Stag1 loss on self-renewal in vivo. We observed reduced Stag2-deficient derived chimerism in the peripheral blood of mice reconstituted with Stag2 KO and WT competitor cells (p<0.001; Figure S2D -F). However, within the bone marrow of transplant recipient mice, we found a significant increase in Stag2 KO derived chimerism, which was most significant in the LSK 15 compartment (p<0.001) including in LT-HSCs (p<0.001; Figure 1C ) but not in lineage positive cells (p≤0.37). Stag1 loss did not impact in vivo self-renewal or differentiation output ( Figure 1D ; S2G-I). These data suggest that Stag2 loss induces both an increase in self-renewal and reduced differentiation capacity in HSCs, which are critical features of hematopoietic transformation.
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To determine if Stag2 loss was associated with the expansion of hematopoietic cells with clonal cytogenetic alterations, we performed karyotype analysis in Stag2 and Stag1 WT and KO bone marrow cells. Chromosomal aberrations by metaphase karyotyping were not detected in either
Stag2-or Stag1-deficient hematopoietic cells (n=7; Figure S3A -B). We did observe an increase in the proportion of cells with premature sister chromatid separation in Stag2 KO bone marrow
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( Figure S3C) ; however, consistent with metaphase cytogenetics, we did not observe clonal copy number alterations on low-pass whole genome sequencing ( Figure S3D -E). This data suggested that the increase in hematopoietic self-renewal induced by Stag2 loss is not due to genomic instability and resultant clonal evolution.
Stag2 and Stag1 co-deletion is synthetic lethal. 5 The observation that Stag2-deficient HSCs displayed increased self-renewal is in contrast to the lethality observed with loss of the core cohesin component Smc3 in hematopoietic cells (19) . We next sought to evaluate potential compensatory function among the Stag paralogs. We found Stag1 transcript and protein expression was significantly increased in Stag2 KO hematopoietic Figure 1E ; Figure S4F ). Stag1/Stag2 deficient mice were characterized by pancytopenia and bone marrow aplasia, consistent with redundancy in hematopoietic function and in alignment with the absolute requirement for core cohesin complex members ( Figure 1F ). Similar to mice with bi-allelic deletion of Smc3, we observed marked 25 chromosomal alterations on metaphase spreads of the Stag1/Stag2 deleted bone marrow ( Figure S4G ). Collectively, these data suggest a role for Stag2 in gene regulation and tumor suppression that is not shared with Stag1, whereas they have a shared, redundant role in chromosomal segregation.
Stag2 alters transcriptional lineage commitment. 5 We hypothesized that Figure 1G , S5F bottom panel) even at the earliest HSC states, consistent 5 with negative enrichment for cell specification. We expanded upon these findings by comparing bulk LSK differentially expressed genes to gene expression data from dormant and active HSCs separately isolated through genetic lineage tracing studies(33). We observed that genes that were decreased in expression in Stag2-deficient mice were most highly expressed in slow-cycling quiescent HSCs, while the upregulated genes were most highly expressed in the proliferative
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MPP1 fraction (LSK, Cd34 + , Flt3 -) ( Figure S5G ). Similar findings were observed when comparing our data to single cell RNA-seq data, such that the most downregulated genes in Stag2-deficient LSKs were most highly expressed in the most quiescent HSCs ( Figure S5H ). Collectively, these analyses highlight a transcriptional signature associated with decreased lineage commitment, decreased quiescence, and enhanced self-renewal in the setting of STAG2 loss.
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Stag2 loss impairs differentiation and induces dysplasia.
To determine the consequences of these transcriptional alterations in vivo, we assessed the phenotype of mice with Stag2-deficient hematopoiesis over time. Hematopoietic-specific Stag2 20 loss resulted in progressive leukopenia (p<0.02) and thrombocytopenia (p<0.01; Figure S6A ). We observed an expansion in myeloid cells and a significant reduction in B lymphocytes (p<0.001; Figure 2A ) in the peripheral blood, which was not seen with Stag1 deletion. Stag2 loss, but not Given the alterations in transcriptional output and differentiation potential, we hypothesized that
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Stag2 loss led to altered chromatin accessibility at differentially expressed loci. We therefore Figure 2J ). Similarly, Stag2-deficient CFU-Es had increased expression of genes normally Stag1/2 possess shared and independent chromatin binding.
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It has been shown using in vitro model systems that cohesin is essential for genomic cisinteractions and that rapid depletion of cohesin ring members result in complete loss of interphase architecture (3, 14, 38) . However, these model systems do not reflect a physiologic loss/partial loss of a cohesin complex member akin to the genomic alterations observed in either human 20 cancers or the germline cohesinopathy, Cornelia de Lange syndrome(39). As the complete loss of cohesin structural loop components may not be compatible with a viable cell division event, the absence of transcriptional changes observed using in vitro systems of cohesin degradation (14) may not reflect the pathophysiology of Stag2 loss of function. We next sought to determine how 
Loss of chromatin insulation impairs transcriptional output.
Stag1 was able to bind a subset of loci previously occupied by Stag2 or both Stag1 and Stag2 in underlying these changes, we performed motif enrichment on peaks with concomitant reduction in accessibility/gene expression. We observed enrichment for Gata, Ebf, and E2A targets ( Figure   4B ), but not for Cebpb motifs. The genes associated with loss of insulation by ISC significantly overlapped with those loci with decreased accessibility and decreased expression, with Ebf1 and
Pax5 among the genes with the greatest magnitude of insulation change ( Figure 4C , S8B-D). We 25 therefore performed motif analysis on Stag1/2 common and Stag2-specific sites by dichotomizing those that were bound and not bound by CTCF. As expected, loci with shared Stag1/Stag2 occupancy and CTCF binding sites were enriched for CTCF and CTCFL (BORIS) binding motifs.
By contrast, Stag2-specific loci (not bound by Stag1) were enriched for key lineage-specific transcription factor motifs including ERG, IRF8, and PU.1 ( Figure 4D ). These transcription factors are essential for myeloid and lymphoid development (44, 45) and attenuated function of these 5 transcription factors has transformative potential in murine(37) and human hematopoietic cells(46-48).
Altered Ebf1 chromatin structure results in B-cell blockade. 10 We next sought to determine if the altered expression of hematopoietic transcription factors was due to alterations in the population distribution in HSPC or was due to altered expression of these Figure   5I ). Moreover, Ebf1-expressing Stag2 KO progenitors had decreased cKit expression ( Figure 5J) and Ebf1 restoration abrogated the serial replating capacity of Stag2-deficient cells ( Figure 5K ).
Taken together, these data demonstrate a key role for Stag2-mediated regulation of Ebf1 25 expression in modulating the balance between hematopoietic differentiation and self-renewal.
Discussion
The cohesin complex is essential in pleiotropic cellular and gene regulatory functions, including 5 in chromosome segregation (10, 11) and in maintaining DNA interactions (3, 14) which regulate gene expression (13, 15, 16 and GFP + cells were plated in either B-cell colony methylcellulose or stem cell methylcellulose.
As in C-D, cells were harvested after 7 days and analyzed by flow cytometry for I) mature cell markers including the B marker B220 or J) stem cell markers including cKit. K) Cells plated in stem cell methylcellulose were serially replated with exhaustion of Stag2 KO cell overexpressing Ebf1.
